TRIBE-open-paren-2-close-paren-_2A: TRIBE(2), figure 2A
In raredd/kmdata: A Database of Reconstructed Individual Patient Level Data from Oncology Clinical Trials
TRIBE(2)_2A R Documentation
TRIBE(2), figure 2A
Description
Kaplan-Meier digitized data from TRIBE(2), figure 2A (PMID 25970050). A reported sample size of 508 for a primary endpoint of PFS in colorectal cancer.
Usage
`TRIBE(2)_2A`
Format
A data frame of 508 observations and 3 variables:
time event time (in months)
event PFS event indicator (0: no event, 1: event)
arm treatment arms (folfiri_bevacizumab, folfoxiri_bevacizumab)
Source
Mayer RJ, Van Cutsem E, Falcone A, et al. Randomized trial of TAS-102
for refractory metastatic colorectal cancer. N Engl J Med 2015; 372:
1909–19.
Examples
summary(`TRIBE(2)_2A`)
kmplot(`TRIBE(2)_2A`)
raredd/kmdata documentation built on June 15, 2025, 9:33 a.m.
R Package Documentation
Browse R Packages
We want your feedback!
Note that we can't provide technical support on individual packages. You should contact the package authors for that.
| TRIBE(2)_2A | R Documentation |
TRIBE(2), figure 2A
Description
Kaplan-Meier digitized data from TRIBE(2), figure 2A (PMID 25970050). A reported sample size of 508 for a primary endpoint of PFS in colorectal cancer.
Usage
`TRIBE(2)_2A`
Format
A data frame of 508 observations and 3 variables:
time | event time (in months) | |
event | PFS event indicator (0: no event, 1: event) |
|
arm | treatment arms (folfiri_bevacizumab, folfoxiri_bevacizumab) | |
Source
Mayer RJ, Van Cutsem E, Falcone A, et al. Randomized trial of TAS-102 for refractory metastatic colorectal cancer. N Engl J Med 2015; 372: 1909–19.
Examples
summary(`TRIBE(2)_2A`)
kmplot(`TRIBE(2)_2A`)
R Package Documentation
Browse R Packages
We want your feedback!
Note that we can't provide technical support on individual packages. You should contact the package authors for that.
Embedding an R snippet on your website
Add the following code to your website.
For more information on customizing the embed code, read Embedding Snippets.